{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T01:43:32Z","timestamp":1706579012728},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12890-015-0157-1","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T01:46:03Z","timestamp":1449884763000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis"],"prefix":"10.1186","volume":"15","author":[{"given":"Kate","family":"Skolnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjani","family":"Somayaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina S.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Surette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey R.","family":"Rabin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Parkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,12]]},"reference":[{"issue":"2","key":"157_CR1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3476(98)70441-X","volume":"132","author":"A Hamosh","year":"1998","unstructured":"Hamosh A, FitzSimmons SC, Macek Jr M, Knowles MR, Rosenstein BJ, Cutting GR. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr. 1998;132(2):255\u20139.","journal-title":"J Pediatr"},{"issue":"9358","key":"157_CR2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(03)12567-6","volume":"361","author":"F Ratjen","year":"2003","unstructured":"Ratjen F, Doring G. Cystic fibrosis. Lancet. 2003;361(9358):681\u20139.","journal-title":"Lancet"},{"issue":"2","key":"157_CR3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jcf.2014.07.010","volume":"14","author":"G Alicandro","year":"2015","unstructured":"Alicandro G, Frova L, Di Fraia G, Colombo C. Cystic fibrosis mortality trend in Italy from 1970 to 2011. J Cyst Fibros. 2015;14(2):267\u201374.","journal-title":"J Cyst Fibros"},{"issue":"5","key":"157_CR4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0092-8674(00)80570-X","volume":"96","author":"WB Guggino","year":"1999","unstructured":"Guggino WB. Cystic fibrosis and the salt controversy. Cell. 1999;96(5):607\u201310.","journal-title":"Cell"},{"issue":"5","key":"157_CR5","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1034\/j.1399-3003.1999.13e39.x","volume":"13","author":"E Houtmeyers","year":"1999","unstructured":"Houtmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M. Regulation of mucociliary clearance in health and disease. Eur Respir J. 1999;13(5):1177\u201388.","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"157_CR6","first-page":"13","volume":"15","author":"E Mahenthiralingam","year":"2014","unstructured":"Mahenthiralingam E. Emerging cystic fibrosis pathogens and the microbiome. Paediatr Respir Rev. 2014;15 Suppl 1:13\u20135.","journal-title":"Paediatr Respir Rev"},{"key":"157_CR7","first-page":"32","volume-title":"The Canadian cystic fibrosis registry: 2013 annual data report","author":"Canadian Cystic Fibrosis Foundation","year":"2015","unstructured":"Canadian Cystic Fibrosis Foundation. The Canadian cystic fibrosis registry: 2013 annual data report. 2015. p. 32\u20133."},{"issue":"5","key":"157_CR8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0022-3476(05)82653-8","volume":"116","author":"E Kerem","year":"1990","unstructured":"Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr. 1990;116(5):714\u20139.","journal-title":"J Pediatr"},{"issue":"12","key":"157_CR9","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1128\/JCM.42.12.5537-5541.2004","volume":"42","author":"B Fauroux","year":"2004","unstructured":"Fauroux B, Hart N, Belfar S, Boule M, Tillous-Borde I, Bonnet D, et al. Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients. J Clin Microbiol. 2004;42(12):5537\u201341.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"157_CR10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/rccm.200503-344OC","volume":"173","author":"LA Kalish","year":"2006","unstructured":"Kalish LA, Waltz DA, Dovey M, Potter-Bynoe G, McAdam AJ, Lipuma JJ, et al. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am J Respir Crit Care Med. 2006;173(4):421\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"157_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/QCO.0000000000000047","volume":"27","author":"LK Tan","year":"2014","unstructured":"Tan LK, Eccersley LR, Sriskandan S. Current view of haemolytic streptococcal infections. Curr Opin Infect Dis. 2014;27:155\u201364.","journal-title":"Curr Opin Infect Dis"},{"issue":"10","key":"157_CR12","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrmicro2648","volume":"9","author":"JN Cole","year":"2011","unstructured":"Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol. 2011;9(10):724\u201336.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"157_CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(03)00576-0","volume":"3","author":"AL Bisno","year":"2003","unstructured":"Bisno AL, Brito MO, Collins CM. Molecular basis of group A streptococcal virulence. Lancet Infect Dis. 2003;3(4):191\u2013200.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"157_CR14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archinte.163.4.467","volume":"163","author":"MP Muller","year":"2003","unstructured":"Muller MP, Low DE, Green KA, Simor AE, Loeb M, Gregson D, et al. Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario, Canada. Arch Intern Med. 2003;163(4):467\u201372.","journal-title":"Arch Intern Med"},{"issue":"10","key":"157_CR15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","volume":"331","author":"HJ Fuchs","year":"1994","unstructured":"Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The pulmozyme study group. N Engl J Med. 1994;331(10):637\u201342.","journal-title":"N Engl J Med"},{"issue":"7","key":"157_CR16","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1128\/JCM.00414-10","volume":"48","author":"CD Sibley","year":"2010","unstructured":"Sibley CD, Sibley KA, Leong TA, Grinwis ME, Parkins MD, Rabin HR, et al. The Streptococcus milleri population of a cystic fibrosis clinic reveals patient specificity and intraspecies diversity. J Clin Microbiol. 2010;48(7):2592\u20134.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"157_CR17","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/JCM.33.9.2233-2239.1995","volume":"33","author":"FC Tenover","year":"1995","unstructured":"Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233\u20139.","journal-title":"J Clin Microbiol"},{"key":"157_CR18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12890-015-0041-z","volume":"15","author":"CS Thornton","year":"2015","unstructured":"Thornton CS, Brown EL, Alcantara J, Rabin HR, Parkins MD. Prevalence and impact of Streptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study. BMC Pulm Med. 2015;15:49.","journal-title":"BMC Pulm Med"},{"key":"157_CR19","series-title":"CLSI document M02-A10","volume-title":"Performance standards for antimicrobial disk susceptibility tests; approved standard-tenth edition","author":"CLSI","year":"2009","unstructured":"CLSI. Performance standards for antimicrobial disk susceptibility tests; approved standard-tenth edition, CLSI document M02-A10. 2009. Clinical and Laboratory Standards Institute."},{"key":"157_CR20","first-page":"1","volume-title":"Clinical and laboratory standards institute","author":"CLSI","year":"2009","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. In: (CLSI) CaLSI, editor. Clinical and laboratory standards institute. 2009. p. 1\u2013156."},{"issue":"2","key":"157_CR21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1128\/JCM.01807-09","volume":"48","author":"ME Grinwis","year":"2010","unstructured":"Grinwis ME, Sibley CD, Parkins MD, Eshaghurshan CS, Rabin HR, Surette MG. Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis. J Clin Microbiol. 2010;48(2):395\u2013401.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"157_CR22","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1073\/pnas.96.4.1639","volume":"96","author":"MG Surette","year":"1999","unstructured":"Surette MG, Miller MB, Bassler BL. Quorum sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer production. Proc Natl Acad Sci U S A. 1999;96(4):1639\u201344.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"157_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","volume":"2","author":"TWR Lee","year":"2003","unstructured":"Lee TWR, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cystic Fibros. 2003;2:29\u201334.","journal-title":"J Cystic Fibros"},{"issue":"6","key":"157_CR24","first-page":"1465","volume":"69","author":"MT Vincent","year":"2004","unstructured":"Vincent MT, Celestin N, Hussain AN. Pharyngitis. Am Fam Physician. 2004;69(6):1465\u201370.","journal-title":"Am Fam Physician"},{"issue":"11","key":"157_CR25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","volume":"5","author":"JR Carapetis","year":"2005","unstructured":"Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685\u201394.","journal-title":"Lancet Infect Dis"},{"key":"157_CR26","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archinte.1997.00440360129015","volume":"157","author":"BJ Marston","year":"1997","unstructured":"Marston BJ, Plouffe JF, File Jr TM, Hackman BA, Salstrom SJ, Lipman HB, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio The Community-Based Pneumonia Incidence Study Group. Arch Intern Med. 1997;157:1709\u201318.","journal-title":"Arch Intern Med"},{"issue":"1","key":"157_CR27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3201\/eid2001.130233","volume":"20","author":"M Santagati","year":"2014","unstructured":"Santagati M, Spanu T, Scillato M, Santangelo R, Cavallaro F, Arena V, et al. Rapidly fatal hemorrhagic pneumonia and group A Streptococcus serotype M1. Emerg Infect Dis. 2014;20(1):98\u2013101.","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"157_CR28","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/JCM.30.10.2740-2742.1992","volume":"30","author":"GV Doern","year":"1992","unstructured":"Doern GV, Brogden-Torres B. Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol. 1992;30(10):2740\u20132.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"157_CR29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/514631","volume":"27","author":"JL Burns","year":"1998","unstructured":"Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, Louden L, et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis. 1998;27(1):158\u201363.","journal-title":"Clin Infect Dis"},{"issue":"23","key":"157_CR30","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.2010.791","volume":"303","author":"EC Dasenbrook","year":"2010","unstructured":"Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA. 2010;303(23):2386\u201392.","journal-title":"JAMA"},{"issue":"8","key":"157_CR31","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.200802-327OC","volume":"178","author":"EC Dasenbrook","year":"2008","unstructured":"Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med. 2008;178(8):814\u201321.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"157_CR32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","volume":"182","author":"DB Sanders","year":"2010","unstructured":"Sanders DB, Bittner RC, Rosenfeld M, Hoffman LR, Redding GJ, Goss CH. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med. 2010;182(5):627\u201332.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"157_CR33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ppul.1950120306","volume":"12","author":"RL Henry","year":"1992","unstructured":"Henry RL, Mellis CM, Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol. 1992;12(3):158\u201361.","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"157_CR34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.293.5.581","volume":"293","author":"Z Li","year":"2005","unstructured":"Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA. 2005;293(5):581\u20138.","journal-title":"JAMA"},{"issue":"4","key":"157_CR35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ppul.2009.abs","volume":"32","author":"MR Kosorok","year":"2001","unstructured":"Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001;32(4):277\u201387.","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"157_CR36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","volume":"34","author":"J Emerson","year":"2002","unstructured":"Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34(2):91\u2013100.","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"157_CR37","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1099\/mic.0.050989-0","volume":"157","author":"IN Silva","year":"2011","unstructured":"Silva IN, Ferreira AS, Becker JD, Zlosnik JE, Speert DP, He J, et al. Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence. Microbiology. 2011;157(11):3124\u201337.","journal-title":"Microbiology"},{"issue":"5","key":"157_CR38","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/655663","volume":"202","author":"JE Zlosnik","year":"2010","unstructured":"Zlosnik JE, Speert DP. The role of mucoidy in virulence of bacteria from the Burkholderia cepacia complex: a systematic proteomic and transcriptomic analysis. J Infect Dis. 2010;202(5):770\u201381.","journal-title":"J Infect Dis"},{"issue":"12","key":"157_CR39","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s10096-013-1916-7","volume":"32","author":"J Manos","year":"2013","unstructured":"Manos J, Hu H, Rose BR, Wainwright CE, Zablotska IB, Cheney J, et al. Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis. Eur J Clin Microbiol Infect Dis. 2013;32(12):1583\u201392.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Pt 9","key":"157_CR40","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1099\/jmm.0.063412-0","volume":"63","author":"NM Karaky","year":"2014","unstructured":"Karaky NM, Araj GF, Tokajian ST. Molecular characterization of Streptococcus pyogenes group A isolates from a tertiary hospital in Lebanon. J Med Microbiol. 2014;63(Pt 9):1197\u2013204.","journal-title":"J Med Microbiol"},{"issue":"6","key":"157_CR41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4161\/viru.21540","volume":"3","author":"AL Borek","year":"2012","unstructured":"Borek AL, Obszanska K, Hryniewicz W, Sitkiewicz I. Detection of Streptococcus pyogenes virulence factors by multiplex PCR. Virulence. 2012;3(6):529\u201333.","journal-title":"Virulence"},{"issue":"10","key":"157_CR42","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1128\/IAI.71.10.5633-5639.2003","volume":"71","author":"MJ Marouni","year":"2003","unstructured":"Marouni MJ, Sela S. The luxS gene of Streptococcus pyogenes regulates expression of genes that affect internalization by epithelial cells. Infect Immun. 2003;71(10):5633\u20139.","journal-title":"Infect Immun"},{"key":"157_CR43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1471-2180-8-188","volume":"8","author":"M Siller","year":"2008","unstructured":"Siller M, Janapatla RP, Pirzada ZA, Hassler C, Zinkl D, Charpentier E. Functional analysis of the group A streptococcal luxS\/AI-2 system in metabolism, adaptation to stress and interaction with host cells. BMC Microbiol. 2008;8:188.","journal-title":"BMC Microbiol"},{"issue":"5","key":"157_CR44","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1046\/j.1365-2958.2003.03803.x","volume":"50","author":"K Duan","year":"2003","unstructured":"Duan K, Dammel C, Stein J, Rabin H, Surette MG. Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol. 2003;50(5):1477\u201391.","journal-title":"Mol Microbiol"},{"key":"157_CR45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4137\/MBI.S12996","volume":"6","author":"M Camara","year":"2013","unstructured":"Camara M, Dieng A, Boye CS. Antibiotic susceptibility of streptococcus pyogenes isolated from respiratory tract infections in dakar, senegal. Microbiol Insights. 2013;6:71\u20135.","journal-title":"Microbiol Insights"},{"key":"157_CR46","unstructured":"http:\/\/www.cysticfibrosisdata.org\/ReportsUS.html . Accessed May 15 2015."},{"key":"157_CR47","unstructured":"http:\/\/www.cysticfibrosis.org.uk\/media\/598466\/annual-data-report-2013-jul14.pdf . Accessed April 20 2015."},{"issue":"31","key":"157_CR48","first-page":"681","volume":"48","author":"P Stepak","year":"1999","unstructured":"Stepak P, Roberts MC, Goldoft M, Kobayashi J. Use of pulsed-field Gel electrophoresis for investigation of a cluster of invasive group a streptococcal illness - Spokane, Washington. MMWR Morb Mortal Wkly Rep. 1999;48(31):681\u20133. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm4831a1.htm . Accessed October 6 2015.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"157_CR49","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1128\/AAC.01133-12","volume":"56","author":"C Silva-Costa","year":"2012","unstructured":"Silva-Costa C, Fri\u00e3es A, Ramirez M, Melo-Cristino J, The Portuguese Group for the Study of Streptococcal Infections. Differences between macrolide-resistant and \u2013 susceptible streptococcus pyogenes: importance of clonal properties in addition to antibiotic consumption. Antimicrob Agents Chemother. 2012;56(11):5661\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"157_CR50","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1128\/JCM.02536-05","volume":"44","author":"JA Carri\u00e7o","year":"2006","unstructured":"Carri\u00e7o JA, Silva-Costa C, Melo-Cristino J, Pinto FR, de Lencastre H, Almeida JS, et al. Illustration of a common framework for relating multiple typing methods by application to macrolide- resistant streptococcus pyogenes. J Clin Microbiol. 2006;44(7):2524\u201332.","journal-title":"J Clin Microbiol"},{"key":"157_CR51","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(09)70178-1","volume":"9","author":"AC Steer","year":"2009","unstructured":"Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis. 2009;9:611\u20136.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"157_CR52","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/JCM.03554-13","volume":"52","author":"S Teatero","year":"2014","unstructured":"Teatero S, McGeer A, Low DE, Li A, Demczuk W, Martin I, et al. Characterization of invasive group B streptococcus strains from the greater Toronto Area, Canada. J Clin Microbiol. 2014;52(5):1441\u20137.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"157_CR53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcf.2010.11.003","volume":"10","author":"Y Maeda","year":"2011","unstructured":"Maeda Y, Elborn JS, Parkins MD, Reihill J, Goldsmith CE, Coulter WA, et al. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF). J Cyst Fibros. 2011;10(2):133\u20139.","journal-title":"J Cyst Fibros"},{"issue":"Pt 5","key":"157_CR54","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1099\/jmm.0.016592-0","volume":"59","author":"CD Sibley","year":"2010","unstructured":"Sibley CD, Grinwis ME, Field TR, Parkins MD, Norgaard JC, Gregson DB, et al. McKay agar enables routine quantification of the \u2018Streptococcus milleri\u2019 group in cystic fibrosis patients. J Med Microbiol. 2010;59(Pt 5):534\u201340.","journal-title":"J Med Microbiol"},{"issue":"39","key":"157_CR55","doi-asserted-by":"crossref","first-page":"15070","DOI":"10.1073\/pnas.0804326105","volume":"105","author":"CD Sibley","year":"2008","unstructured":"Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A. 2008;105(39):15070\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"157_CR56","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/JCM.01362-09","volume":"48","author":"M Yoshino","year":"2010","unstructured":"Yoshino M, Murayama SY, Sunaoshi K, Wajima T, Takahashi M, Masaki J, et al. Nonhemolytic Streptococcus pyogenes isolates that lack large regions of the sag operon mediating streptolysin S production. J Clin Microbiol. 2010;48(2):635\u20138.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"157_CR57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/CMR.00068-09","volume":"23","author":"JJ Lipuma","year":"2010","unstructured":"Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev. 2010;23(2):299\u2013323.","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 1","key":"157_CR58","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1513\/AnnalsATS.201306-159MG","volume":"11","author":"MG Surette","year":"2014","unstructured":"Surette MG. The cystic fibrosis lung microbiome. Ann Am Thorac Soc. 2014;11 Suppl 1:S61\u20135.","journal-title":"Ann Am Thorac Soc"},{"issue":"3\u20134","key":"157_CR59","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijmm.2014.02.008","volume":"304","author":"P Barillova","year":"2014","unstructured":"Barillova P, Tchesnokova V, Dubbers A, Kuster P, Peters G, Dobrindt U, et al. Prevalence and persistence of Escherichia coli in the airways of cystic fibrosis patients an unrecognized CF pathogen? Int J Med Microbiol. 2014;304(3\u20134):415\u201321.","journal-title":"Int J Med Microbiol"},{"issue":"3","key":"157_CR60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jcf.2015.03.012","volume":"14","author":"MD Parkins","year":"2015","unstructured":"Parkins MD, Floto RA. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis. J Cyst Fibros. 2015;14(3):293\u2013304.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"157_CR61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2013.06.004","volume":"13","author":"C Etherington","year":"2014","unstructured":"Etherington C, Naseer R, Conway SP, Whitaker P, Denton M, Peckham DG. The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation. J Cyst Fibros. 2014;13(1):49\u201355.","journal-title":"J Cyst Fibros"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-015-0157-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T14:43:02Z","timestamp":1599921782000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2466\/15\/161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["157"],"URL":"https:\/\/doi.org\/10.1186\/s12890-015-0157-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"161"}}